Tesamorelin
Growth-hormone-releasing-hormone analog studied for visceral adipose tissue reduction and body composition shifts.
This compound has an established clinical pathway, but our licensed pharmacy partners do not currently compound it, so Allora does not dispense it today. Join the waitlist and we will notify you when it becomes available.
Mechanism of action
How Tesamorelin works
Stimulates pulsatile release of endogenous growth hormone, which favors visceral fat lipolysis and improvements in lean mass over time.
Areas of study
What Tesamorelin is studied for
- check
Visceral adipose tissue reduction
- check
Body composition optimization in metabolically compromised adults
Considerations
Important things your physician will discuss
This is general clinical context — not medical advice. Your evaluation determines whether Tesamorelin is appropriate for you.
- info
Not currently compounded by our licensed pharmacy partners — offered as educational information and waitlist only
- info
Requires baseline metabolic and hormonal labs prior to initiation
- info
Not appropriate during active malignancy or pregnancy
Related peptides
More from the Metabolic category
Semaglutide / Tirzepatide
Incretin-class therapies that modulate appetite, slow gastric emptying, and improve insulin response.
View peptide arrow_outwardLipotropic cofactor blendLipotropic B-12 / MIC
Compounded blend of lipotropic cofactors (methionine, inositol, choline) with methylcobalamin B-12, used to support energy and lipid metabolism.
View peptide arrow_outwardLipolytic GH fragmentAOD-9604
Investigational fragment of human growth hormone studied for fat metabolism without classical GH side effects.
View peptide arrow_outwardCurious whether this peptide fits your protocol?
A licensed Allora physician will review your goals, history, and labs before recommending any therapy.